Product
Cabral
1 clinical trial
1 indication
Indication
bioequivalenceClinical trial
Open-label, Randomized, Single Dose, 4period, Replicated, Cross-over Trial to Assess the Bioequivalence of Feniramidol HCl 400 mg Film Tablet in Comparison With Cabral 400 mg Film Tablet in Healthy Male Subjects Under Fed ConditionsStatus: Completed, Estimated PCD: 2019-07-26